De Novo Drug Design of Potential Inhibitors of SARS-CoV-2 Papain-like Protease
Here, potential inhibitors of the SARS-CoV-2 papain-like protease (PL<sup>pro</sup>) are reported. A drug molecule (PL<sup>pro</sup>-50), designed de novo using generative neural networks, interacts with PL<sup>pro</sup> via hydrogen bonding, forming a salt bridge...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-04-01
|
| Series: | Medical Sciences Forum |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-9992/21/1/37 |